Print

News from the FDA: First-line treatment and biosimilars for prostate cancer

https://www.facingourrisk.org/XRAY/news-from-FDA-PrCa-Aug-2024
Full article: https://www.fda.gov

The FDA recently approved a first-line treatment for non-metastatic, castration-sensitive prostate cancer. Approval was also given to two new drugs known as biosimilars that can be used in place of two already approved biologics to prevent bone weakening, pain or fractures that may occur from certain hormone therapies or from cancer that has spread to the bone. (Posted 9/10/24)

Este artículo está disponible en español.

Questions To Ask Your Health Care Provider

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.